“…Both NMDG permeability and YO-PRO1 uptake via TRPV1 are drastically affected by alterations within the central pore domain, such as mutagenesis, the presence of pore blockers, and cysteine-modifying reagents (10). This is in stark contrast to the TRPM3 omega current, which is completely insensitive to pharmacological blockade and chemical modification of the central pore but is affected by mutations within TM4 (30). Furthermore, the omega pore is impermeable to NMDG, and opening of this pathway does not alter TRPM3 ionic selectivity.…”